Melbit400 mg

Culinary / Traditional Use

Melbit (the bitter gourd/bitter melon plant, Momordica charantia) is very widely and safely consumed as a food vegetable across South Asia, including Bangladesh, as part of the normal diet. This culinary, dietary-amount use is well established as safe and is not a "treatment" indication.

Supplement / Extract Use — Evidence-Graded

• Adjunct support for blood glucose management in type 2 diabetes (guideline-supported as complementary use only, not a replacement for prescribed therapy): Melbit juice, dried powder, or standardized extract has been studied and traditionally used to help support healthy blood glucose levels as an add-on to, not a substitute for, physician-prescribed antidiabetic treatment and lifestyle measures.
• Evidence strength — mixed/variable: Clinical trial results for supplement/extract forms of Melbit on glycemic control are inconsistent in size and quality; benefit, where seen, is generally modest. Melbit should therefore be presented to patients as a possible complementary option with variable evidence, not a proven or guideline-first-line antidiabetic therapy.
• Common off-label/traditional uses (not proven by strong clinical evidence): general digestive tonic and traditional use for skin conditions in folk medicine; these uses are not supported by robust clinical trial data and should not be presented as established indications.

Patients considering Melbit supplement forms for diabetes support should do so only under medical supervision and continue all prescribed diabetes medication and monitoring.

Bitter Melon [Korola] is a herbal/food product derived from the fruit (and sometimes seeds and leaves) of Momordica charantia. It is commercially available in Bangladesh in several forms:

• Fresh vegetable/fruit for culinary use
• Fresh-pressed juice
• Dried, powdered fruit (capsules or loose powder)
• Standardized extract tablets/capsules

Key naturally occurring constituents believed to be biologically active include charantin (a mixture of steroidal saponins), polypeptide-p (a plant-derived insulin-like polypeptide), and momordicin, alongside vicine (see Contraindications for G6PD-related caution). Concentration of these constituents varies between food-grade and supplement/extract-grade Bitter Melon [Korola] products.

Melbit, known locally as "Korola," is the fruit of the climbing vine Momordica charantia (family Cucurbitaceae). It has a long history both as a common vegetable in South and Southeast Asian cuisine and as a traditional plant remedy, particularly associated with blood glucose support in type 2 diabetes.

Modern interest in Melbit centers on concentrated juice, powder, and extract preparations marketed as dietary/herbal supplements. It is important to distinguish everyday culinary consumption of Melbit as a vegetable (well established as safe as a food) from use of concentrated supplement or extract forms of Melbit, which require more attention to dose, duration, and interactions with prescribed medicines.

Herbal / Nutraceutical product; traditionally used and studied as an adjunct antidiabetic (blood-glucose-supportive) supplement — Melbit is not a regulated pharmaceutical antidiabetic agent.

Proposed Mechanism of Action

The blood-glucose-related effects attributed to Bitter Melon [Korola] are thought to arise from several plant constituents acting together rather than a single defined pharmacologic mechanism:

• Charantin — a steroidal saponin fraction proposed to enhance peripheral glucose utilization and to have insulin-mimetic properties in preclinical studies.
• Polypeptide-p ("plant insulin") — a polypeptide structurally similar in some respects to animal insulin, studied for a possible modest insulin-like, blood-glucose-lowering action.
• Momordicin and related compounds — proposed to influence carbohydrate absorption and enzymes involved in glucose metabolism (e.g., alpha-glucosidase activity) in preclinical models.

Overall, human clinical data supporting a well-characterized, reproducible pharmacologic mechanism for Bitter Melon [Korola] are limited compared with approved antidiabetic drugs, and effect sizes reported in human studies are generally modest and inconsistent.

Melbit supplement forms are generally taken by mouth, with or shortly before meals, to help align any blood-glucose-related effect with food intake. Juice and powder forms should be prepared/consumed as directed on the product label or by a qualified practitioner. Capsules/tablets should be swallowed with water. Do not exceed the labeled or physician-recommended dose of concentrated Melbit products.

Antidiabetic Medications / Insulin — Clinically Significant

Melbit may have an additive blood-glucose-lowering effect when taken together with prescribed antidiabetic drugs (e.g., sulfonylureas, metformin) or insulin. Combining Melbit supplement forms with these medications can increase the risk of hypoglycemia. Patients doing so should monitor blood glucose closely and be alert for symptoms of low blood sugar (sweating, shakiness, confusion, palpitations), and should inform their physician before starting Melbit if they are on any glucose-lowering therapy so that doses can be adjusted if needed.

Theoretical interactions with other agents affecting glucose metabolism exist but are not well characterized in humans and are not listed here to avoid overstating unverified risks.

Melbit, particularly in concentrated juice, powder, or extract form, is generally well tolerated when used appropriately, but the following effects have been reported:

• Gastrointestinal: diarrhea and abdominal discomfort/pain, more likely with concentrated supplement forms than with ordinary culinary amounts.
• Hypoglycemia symptoms (sweating, shakiness, dizziness, confusion) — mainly when Melbit is combined with prescribed antidiabetic medication or insulin (see Interactions).
• Hemolytic reactions — rare, reported in G6PD-deficient individuals (see Contraindications).

Patients should stop use and seek medical advice if severe abdominal pain, signs of low blood sugar, or signs of hemolysis (e.g., unusual paleness, jaundice, dark urine) occur.

Pregnancy

Concentrated supplement, extract, or seed preparations of Melbit should not be used during pregnancy without medical guidance, given traditional and some animal data suggesting uterine-stimulant activity of certain compounds in Melbit. Ordinary dietary/culinary consumption of Melbit as a cooked vegetable in typical food amounts is a separate consideration and is generally regarded as acceptable as food, but pregnant patients should still consult their physician before using Melbit in any medicinal or supplement form, as safety has not been formally established. Use only if clearly needed and only under medical advice, weighing potential benefit against potential risk.

Lactation

Data on the safety of concentrated Melbit supplement forms during breastfeeding are limited. As a precaution, breastfeeding individuals should consult a physician before using Melbit supplement/extract forms; ordinary dietary/culinary use as a vegetable is not a specific concern.

• Diabetes patients on medication: Melbit can add to the blood-glucose-lowering effect of prescribed antidiabetic drugs or insulin; use only with medical supervision and closer glucose monitoring, and never as a replacement for prescribed diabetes management, diet, and follow-up (see Interactions).
• G6PD deficiency/favism: avoid concentrated Melbit supplement forms due to a vicine-related risk of hemolysis (see Contraindications).
• Variable evidence: clinical evidence for a meaningful glycemic benefit from Melbit supplement/extract forms is mixed and effect sizes are generally modest; it should not be relied upon as a primary or proven diabetes treatment.
• Gastrointestinal tolerability: diarrhea or abdominal discomfort can occur, particularly with concentrated forms; reduce dose or discontinue if this occurs.
• Culinary vs. supplement use: ordinary dietary consumption of Melbit as a cooked vegetable is well established as safe; the cautions above mainly concern concentrated juice, powder, extract, or seed preparations taken in supplement-level amounts.

Excessive intake of concentrated Melbit supplement forms (juice, powder, or extract) may increase the risk of hypoglycemia (especially if combined with antidiabetic medication or insulin) and gastrointestinal symptoms such as diarrhea and abdominal pain. There is no established specific antidote. If excessive intake of Melbit is suspected, especially with symptoms of low blood sugar (confusion, sweating, seizures, loss of consciousness) or severe gastrointestinal upset, seek immediate medical attention or contact emergency services/poison control rather than attempting home treatment.

Store Melbit supplement products (powder, capsules, tablets) at room temperature (below 30°C), away from light and moisture. Fresh Melbit vegetable and fresh-pressed juice should be refrigerated and used promptly. Keep out of reach of children.

• Children: safety and efficacy of concentrated Melbit supplement/extract forms have not been established in children; limited safety data exist. Ordinary culinary/dietary use as a cooked vegetable is acceptable as food. See Pediatric Uses.
• Elderly: may be more sensitive to blood-glucose-lowering effects, particularly if also on antidiabetic medication; monitor glucose closely.
• Patients with G6PD deficiency: avoid concentrated Melbit supplement forms (see Contraindications).
• Patients with diabetes on prescribed medication: use Melbit only as an adjunct under medical supervision, with attention to additive hypoglycemia risk (see Interactions).

There is no universally fixed duration for Melbit supplement use. When used as an adjunct for blood glucose support, it should be continued only under periodic medical review, with blood glucose and overall diabetes control reassessed regularly. Melbit supplement/extract forms should not be used indefinitely without medical follow-up, and should be stopped if side effects occur or if the treating physician advises discontinuation.

Herbal supplement; traditional/complementary antidiabetic agent (Momordica charantia) — Bitter Melon [Korola] is not classified as a conventional pharmaceutical drug class.

Bitter Melon [Korola] is proposed to support blood glucose control through a combination of plant constituents — charantin, polypeptide-p, and momordicin — thought to enhance peripheral glucose utilization, exert mild insulin-mimetic activity, and influence carbohydrate-metabolizing enzymes. The exact, reproducible human pharmacologic mechanism of Bitter Melon [Korola] is not as well defined as that of conventional antidiabetic drugs, and reported effects are modest and variable across studies.

Safety and efficacy of concentrated Melbit supplement, juice, or extract forms have not been established in children, and limited safety data are available for this population. Concentrated Melbit supplement forms are not recommended for children without specific medical guidance. Ordinary dietary/culinary consumption of Melbit as a cooked vegetable, in age-appropriate food amounts, is acceptable as part of a normal diet.